Transplant Hepatology Research

Advancing Care for Patients with Liver Disease

Providing the highest level of care through a multidisciplinary approach, our dedicated team conducts research to improve health and advance care for patients with chronic liver disease or liver transplantation.

With a focus on Phase II - III clinical trials, our team of hepatologists, clinical research nurses and coordinators, pharmacists, surgeons and other specialists works together to integrate innovative translational research with evidence-based clinical research, giving patients access to optimal care and therapies.

Our current areas of research include:

• Autoimmune hepatitis
• Cirrhosis
• Hepatocellular carcinoma
• Liver transplantation
• Nonalcoholic liver fatty disease (NAFLD)
• Primary biliary cirrhosis
• Primary sclerosing cholangitis
• Value-based care in liver disease
• Viral hepatitis

Our research team has contributed to:

• The cure for Hepatitis C
• Therapy of nonalcoholic fatty liver disease
• Novel, innovative therapy for primary biliary cholangitis and primary sclerosing cholangitis
• Developing biomarkers for liver fibrosis
• Successfully reducing 30- and 90-day readmissions by 50 percent after liver transplant